Royal Bank of Canada’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $135K | Buy |
10,108
+8,302
| +460% | +$111K | ﹤0.01% | 5094 |
|
|
2025
Q1 | $18K | Sell |
1,806
-9,450
| -84% | -$94.2K | ﹤0.01% | 5575 |
|
|
2024
Q4 | $178K | Buy |
11,256
+6,530
| +138% | +$103K | ﹤0.01% | 4456 |
|
|
2024
Q3 | $274K | Buy |
4,726
+193
| +4% | +$11.2K | ﹤0.01% | 4144 |
|
|
2024
Q2 | $208K | Buy |
4,533
+2,024
| +81% | +$92.9K | ﹤0.01% | 4360 |
|
|
2024
Q1 | $166K | Sell |
2,509
-6,418
| -72% | -$425K | ﹤0.01% | 4411 |
|
|
2023
Q4 | $355K | Buy |
8,927
+3,804
| +74% | +$151K | ﹤0.01% | 4069 |
|
|
2023
Q3 | $164K | Sell |
5,123
-12
| -0.2% | -$384 | ﹤0.01% | 4502 |
|
|
2023
Q2 | $206K | Buy |
5,135
+2,743
| +115% | +$110K | ﹤0.01% | 4293 |
|
|
2023
Q1 | $102K | Sell |
2,392
-573
| -19% | -$24.4K | ﹤0.01% | 4788 |
|
|
2022
Q4 | $143K | Buy |
2,965
+2,486
| +519% | +$120K | ﹤0.01% | 4713 |
|
|
2022
Q3 | $18K | Buy |
479
+123
| +35% | +$4.62K | ﹤0.01% | 5693 |
|
|
2022
Q2 | $10K | Sell |
356
-879
| -71% | -$24.7K | ﹤0.01% | 5919 |
|
|
2022
Q1 | $67K | Sell |
1,235
-2,441
| -66% | -$132K | ﹤0.01% | 5422 |
|
|
2021
Q4 | $215K | Buy |
3,676
+2,243
| +157% | +$131K | ﹤0.01% | 4752 |
|
|
2021
Q3 | $57K | Buy |
1,433
+264
| +23% | +$10.5K | ﹤0.01% | 5567 |
|
|
2021
Q2 | $49K | Sell |
1,169
-114
| -9% | -$4.78K | ﹤0.01% | 5567 |
|
|
2021
Q1 | $79K | Buy |
1,283
+837
| +188% | +$51.5K | ﹤0.01% | 5125 |
|
|
2020
Q4 | $31K | Buy |
446
+345
| +342% | +$24K | ﹤0.01% | 5314 |
|
|
2020
Q3 | $4K | Buy |
101
+1
| +1% | +$40 | ﹤0.01% | 5683 |
|
|
2020
Q2 | $4K | Buy |
+100
| New | +$4K | ﹤0.01% | 5626 |
|